EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus

Ines Debove iD, Steffen Paschen iD, Deborah Amstutz iD, Francisco Cardoso iD, Jean-Christophe Corvol iD, Victor S C Fung iD, Anthony E Lang iD, Pablo Martinez Martin iD, María C Rodríguez-Oroz iD, Daniel Weintraub iD, Paul Krack iD, Günther Deuschl iD und 1 weitere

Movement Disorders · 2024

DOI: 10.1002/mds.29700 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Movement Disorders, 2024. Verfasst von Ines Debove und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Parkinson Disease, Mental Disorders, Deep Brain Stimulation, Disruptive, Impulse Control, and Conduct Disorders. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Impulse‐control and related behavioral disorders (ICBDs) significantly impact the lives of Parkinson's disease (PD) patients and caregivers, with lasting consequences if undiagnosed and untreated. While ICBD pathophysiology and risk factors are well‐studied, a standardized severity definition and treatment evidence remain elusive.

Objective

This work aimed to establish international expert consensus on ICBD treatment strategies. To comprehensively address diverse treatment availabilities, experts from various continents were included.

Methods

From 2021 to 2023, global movement disorders specialists engaged in a Delphi process. A core expert group initiated surveys, involving a larger panel in three iterations, leading to refined severity definitions and treatment pathways.

Results

Experts achieved consensus on defining ICBD severity, emphasizing regular PD patient screenings for early detection. General treatment recommendations focused on continuous monitoring, collaboration with significant others, and seeking specialist advice for legal or financial challenges. For mild to severe ICBDs, gradual reduction in dopamine agonists was endorsed, followed by reductions in other PD medications. Second‐line treatment strategies included diverse approaches like reversing the last medication change, cognitive behavior therapy, subthalamic nucleus deep brain stimulation, and specific medications like quetiapine, clozapine, and antidepressants. The panel reached consensus on distinct treatment pathways for punding and dopamine dysregulation syndrome, formulating therapy recommendations. Comprehensive discussions addressed management strategies for the exacerbation of either motor or non‐motor symptoms following the proposed treatments.

Conclusion

The consensus offers in‐depth insights into ICBD management, presenting clear severity criteria and expert consensus treatment recommendations. The study highlights the critical need for further research to enhance ICBD management. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMental DisordersDeep Brain StimulationDisruptive, Impulse Control, and Conduct DisordersHumansDopamineDopamine Agonists

Stichwörter der Autor:innen

Parkinson's diseasedeep brain stimulationimpulse-control and related behavioral disorders

Substanzen

DopamineDopamine Agonists

Autor:innen und Institutionen

  • Department of Neurology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland.
  • Department of Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
  • Movement Disorders Unit, Neurology Service, Internal Medicine Department, The Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Department of Neurology, Sorbonne Université, Paris Brain Institute (ICM), Inserm, CNRS, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.
  • Movement Disorders Unit, Department of Neurology, Westmead Hospital and Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Ines Debove, Steffen Paschen, Deborah Amstutz, Francisco Cardoso, Jean-Christophe Corvol, Victor S C Fung, Anthony E Lang, Pablo Martinez Martin, María C Rodríguez-Oroz, Daniel Weintraub, Paul Krack, Günther Deuschl

Zitieren

APA

Debove, I., Paschen, S., Amstutz, D., Cardoso, F., Corvol, J. C., Fung, V. S. C., Lang, A. E., Martinez Martin, P., Rodríguez-Oroz, M. C., Weintraub, D., Krack, P., Deuschl, G., & the Members of the ICBD in PD Management Consensus Group (2024). Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus. Movement Disorders. https://doi.org/10.1002/mds.29700

Vancouver

Debove I, Paschen S, Amstutz D, Cardoso F, Corvol JC, Fung VSC, et al. Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus. Movement Disorders. 2024. doi:10.1002/mds.29700

BibTeX
@article{Debove2024,
  author = {Debove, Ines and Paschen, Steffen and Amstutz, Deborah and Cardoso, Francisco and Corvol, Jean-Christophe and Fung, Victor S C and Lang, Anthony E and Martinez Martin, Pablo and Rodríguez-Oroz, María C and Weintraub, Daniel and Krack, Paul and Deuschl, Günther and the Members of the ICBD in PD Management Consensus Group, the Members of the ICBD in PD Management Consensus Group},
  title = {Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus},
  journal = {Movement Disorders},
  year = {2024},
  doi = {10.1002/mds.29700}
}
Kostenlos starten →